Slide 1Haileyesus Getahun, MD, PhD, MPH. Stop TB Department, WHO Geneva, Switzerland Tuberculosis among people who inject drugs: urgent actions needed. IHRAs 22 nd International…

Slide 1 Hepatitis C prevention among people who inject drugs: reducing transmission in PWID by scaling up HCV treatment, OST and needle exchange services Matt Hickman, Natasha…

Slide 1 Public Funding of Syringe Exchange in the US: The Challenges of Failures and Successes and the New Heroin Injectors Don Des Jarlais 1, Heidi Bramson 1, Vivian Guardino…

Slide 1 Prevention, Treatment and Care of Hepatitis C among People Who Inject Drugs Jason Grebely, PhD Senior Lecturer Viral Hepatitis Clinical Research Program The Kirby…

Slide 1 Strictly Confidential © 2014 WHY HIGH-QUALITY POPULATION SIZE ESTIMATES OF KEY POPULATIONS ARE IMPORTANT David Wilson HNP - GP World Bank Slide 2 Strictly Confidential…

Slide 1 DPG-AIDS Welcome Michelle Roland, Lead On behalf of DPG-AIDS Slide 2 Ending AIDS Scenario: New HIV Infections Total number of people living with HIV/AIDS (PLWHA)…

Slide 1 The Economics and Financing of Harm Reduction David Wilson and Nicole Fraser, Global HIV/AIDS Program, World Bank David Wilson, University of New South Wales, Australia…

Slide 1 Future HIV Financing Direction: Reality Check Brian Rettmann, PEPFAR Country Coordinator Slide 2 Modeled Impact of New Infections: the Global AIDS Response Scaling…